BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15188792)

  • 1. Prevention of toxoplasmosis during pregnancy--an epidemiologic survey over 22 consecutive years.
    Breugelmans M; Naessens A; Foulon W
    J Perinat Med; 2004; 32(3):211-4. PubMed ID: 15188792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the possibilities for preventing congenital toxoplasmosis.
    Foulon W; Naessens A; Derde MP
    Am J Perinatol; 1994 Jan; 11(1):57-62. PubMed ID: 8155214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy.
    Foulon W; Naessens A; Lauwers S; De Meuter F; Amy JJ
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):363-6. PubMed ID: 3405553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-two years screening for toxoplasmosis in pregnancy: Liege-Belgium.
    Henri T; Jacques S; Rene L
    Scand J Infect Dis Suppl; 1992; 84():84-5. PubMed ID: 1290082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital toxoplasmosis: is screening desirable?
    Foulon W
    Scand J Infect Dis Suppl; 1992; 84():11-7. PubMed ID: 1290068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003.
    Berger F; Goulet V; Le Strat Y; Desenclos JC
    Rev Epidemiol Sante Publique; 2009 Aug; 57(4):241-8. PubMed ID: 19577390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasmosis-related knowledge and practices among pregnant women in the United States.
    Jones JL; Ogunmodede F; Scheftel J; Kirkland E; Lopez A; Schulkin J; Lynfield R
    Infect Dis Obstet Gynecol; 2003; 11(3):139-45. PubMed ID: 15022874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.
    Koskiniemi M; Lappalainen M; Koskela P; Hedman K; Ammälä P; Hiilesmaa V; Teramo K
    Scand J Infect Dis Suppl; 1992; 84():70-4. PubMed ID: 1290079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and prevention of congenital toxoplasmosis: an effectiveness study in a population with a high infection rate.
    Ricci M; Pentimalli H; Thaller R; Ravà L; Di Ciommo V
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):398-403. PubMed ID: 15061319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of congenital toxoplasmosis: official recommendations and management in France].
    Thiebaugeorges O; Schweitzer M
    Arch Pediatr; 2003 Feb; 10 Suppl 1():20. PubMed ID: 12802960
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
    Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
    Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for toxoplasmosis during pregnancy: the situation in Belgium.
    Naessens A
    Arch Pediatr; 2003 Feb; 10 Suppl 1():18. PubMed ID: 12802958
    [No Abstract]   [Full Text] [Related]  

  • 15. [Toxoplasmosis in Poznan region, Poland 1990-2000].
    Pawłowski ZS
    Przegl Epidemiol; 2002; 56(3):409-17. PubMed ID: 12608090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of congenital toxoplasmosis.
    Foulon W; Naessens A; Ho-Yen D
    J Perinat Med; 2000; 28(5):337-45. PubMed ID: 11125923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of preventive programmes against congenital toxoplasmosis.
    Stray-Pedersen B; Jenum P
    Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria.
    Aspöck H; Pollak A
    Scand J Infect Dis Suppl; 1992; 84():32-7. PubMed ID: 1290071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection.
    Rorman E; Zamir CS; Rilkis I; Ben-David H
    Reprod Toxicol; 2006 May; 21(4):458-72. PubMed ID: 16311017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.
    Boyer KM; Holfels E; Roizen N; Swisher C; Mack D; Remington J; Withers S; Meier P; McLeod R;
    Am J Obstet Gynecol; 2005 Feb; 192(2):564-71. PubMed ID: 15696004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.